SECAUCUS, N.J. - Quest Diagnostics (NYSE:DGX) has announced the acquisition of select assets of Steward Health Care System's outreach laboratory services. The acquisition, effective today, is set to enhance laboratory services for patients and physicians in Pennsylvania and Ohio.
The acquired assets will be integrated into Quest's existing full-service laboratory in Pittsburgh, PA, which will now handle testing for the regions previously covered by Steward Health Care's outreach labs. Additionally, Quest is poised to acquire assets from Steward's laboratory business that serves Hawthorn Medical Associates in Dartmouth, MA, pending the transfer of the laboratory license.
Jim Davis, Chairman, CEO and President of Quest Diagnostics, stated, "This transaction delivers on our strategy to serve the evolving needs of health systems, which increasingly seek to entrust their critical laboratory services to our expertise so they can focus on their core care missions." He added that the move is consistent with Quest's growth strategy through accretive outreach laboratory acquisitions and will bolster their service capabilities in Ohio and Pennsylvania.
Quest Diagnostics has a history of collaboration with Steward Health Care, including providing professional lab management services and previous asset acquisitions. This transaction further cements the relationship, aiming to provide innovative, quality, and cost-effective lab services.
Steward Health Care System, known as the largest physician-led, minority-owned integrated health care system in the country, operates 33 hospitals and has a network of over 5,500 providers. Quest Diagnostics empowers health outcomes through insights derived from the world's largest database of clinical lab results, serving a significant portion of American adults and health care professionals each year.
The financial terms of the acquisition have not been disclosed. This development is expected to expand Quest's ability to deliver enhanced diagnostic services and support the health care needs of patients in the affected regions.
This report is based on a press release statement from Quest Diagnostics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.